• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS CARMEDA BIOMEDICUS CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS CARMEDA BIOMEDICUS CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number CB96345-023
Device Problem Mechanical Problem (1384)
Patient Problems Ischemia (1942); Vascular Dissection (3160)
Event Date 11/01/2010
Event Type  Injury  
Manufacturer Narrative
The investigation for this device is ongoing, the results will be supplied in supplemental report.Literature reference - 10.1097/imi.0b013e3182029a83.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation.All data were collected retrospectively from a single center between 2000 to 2008.The study population included 32 patients predominantly male, median age 52.5 years.Medtronic devices used were bio-medicus cannula,bio-medicus centrifugal pump and custom pack, serial numbers not provided.Among all patients, adverse events included: limb ischemia requiring intervention, acute renal failure, deep vein thrombosis and intracardiac clots.Based on the available information, these adverse events were not attributed to medtronic product.Based on the available information a direct correlation could not be made between the observed adverse events and medtronic product.Among all patients, device malfunctions included: mechanical complication of cannulation causing dissection of the femoral artery in one patient leading to ischemia.Based on the available information, these malfunctions may have been attributed to medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Manufacturer Narrative
Continued from block h6: fdc 24 added: information provided by the literature article indicated that the device was used for ecmo; this device is indicated for use for up to six hours or less.Literature details; thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation innovations 2010 author; yoan lamarche et al.Literature reference - 10.1097/imi.0b013e3182029a83 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARMEDA BIOMEDICUS CANNULA
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
MDR Report Key10547629
MDR Text Key212297221
Report Number2184009-2020-00050
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
PMA/PMN Number
K924642
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 11/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCB96345-023
Device Catalogue NumberCB96345-023
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/21/2020
Initial Date FDA Received09/17/2020
Supplement Dates Manufacturer Received11/03/2020
Supplement Dates FDA Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-